INMUNE BIO INC. Financing Cash Flow
INMUNE BIO INC. (INMB) reported Financing Cash Flow of $749.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- INMUNE BIO INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $67.00K.
- INMUNE BIO INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- INMUNE BIO INC. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $22.27M, a 71.35% increase year-over-year.
- INMUNE BIO INC. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $5.27M.
- INMUNE BIO INC. net cash provided by (used in) financing activities for fiscal 2025 was $27.61M, a 51.62% increase from fiscal 2024.
- INMUNE BIO INC. net cash provided by (used in) financing activities for fiscal 2024 was $18.21M.
- INMUNE BIO INC. net cash provided by (used in) financing activities for fiscal 2023 was -$4.22M, a 679.56% decline from fiscal 2022.
- INMUNE BIO INC. net cash provided by (used in) financing activities for fiscal 2022 was $729.00K, a 99.24% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $749.00K 10-Q · filed 2026-08-06 | |||||||
| 2025-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $67.00K derived: sum of 2 quarters · filed 2026-03-30 | $22.34M derived: sum of 3 quarters · filed 2026-08-06 | $27.61M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $22.27M derived: sum of 2 quarters · filed 2026-08-06 | $27.55M 10-Q · filed 2025-10-30 | $25.47M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $22.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $27.55M 10-Q · filed 2026-08-06 | $25.47M derived: sum of 3 quarters · filed 2026-08-06 | $35.26M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $5.27M 10-Q · filed 2026-05-07 | $3.20M derived: sum of 2 quarters · filed 2026-05-07 | $12.99M derived: sum of 3 quarters · filed 2026-05-07 | $25.98M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $7.71M derived: sum of 2 quarters · filed 2026-03-30 | $20.71M derived: sum of 3 quarters · filed 2026-03-30 | $18.21M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $9.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $22.79M derived: sum of 2 quarters · filed 2025-10-30 | $20.29M 10-Q · filed 2025-10-30 | $17.79M derived: sum of 4 quarters · filed 2025-10-30 | ||||
| 2024-06-30 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $10.50M 10-Q · filed 2025-08-07 | $8.00M derived: sum of 3 quarters · filed 2025-08-07 | |||||
| 2024-03-31 | -$2.50M 10-Q · filed 2025-05-08 | -$5.00M derived: sum of 2 quarters · filed 2025-05-08 | ||||||
| 2023-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$4.22M 10-K · filed 2025-03-27 | ||||||
| 2023-09-30 | -$1.73M 10-Q · filed 2024-10-31 | |||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $729.00K 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $729.00K 10-Q · filed 2023-11-01 | $729.00K derived: sum of 4 quarters · filed 2023-11-01 | ||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $729.00K 10-Q · filed 2023-08-07 | $729.00K derived: sum of 3 quarters · filed 2023-08-07 | $53.67M derived: sum of 4 quarters · filed 2023-08-07 | ||||
| 2022-03-31 | $729.00K 10-Q · filed 2023-05-03 | $729.00K derived: sum of 2 quarters · filed 2023-05-03 | $53.67M derived: sum of 3 quarters · filed 2023-05-03 | $68.62M derived: sum of 4 quarters · filed 2023-05-03 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $52.94M derived: sum of 2 quarters · filed 2023-03-02 | $67.89M derived: sum of 3 quarters · filed 2023-03-02 | $96.36M 10-K · filed 2023-03-02 | ||||
| 2021-09-30 | $52.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $67.89M derived: sum of 2 quarters · filed 2022-11-02 | $96.36M 10-Q · filed 2022-11-02 | $96.36M derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | $14.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $43.41M 10-Q · filed 2022-08-03 | $43.41M derived: sum of 3 quarters · filed 2022-08-03 | $66.66M derived: sum of 4 quarters · filed 2022-08-03 | ||||
| 2021-03-31 | $28.46M 10-Q · filed 2022-05-05 | $28.46M derived: sum of 2 quarters · filed 2022-05-05 | $51.70M derived: sum of 3 quarters · filed 2022-05-05 | $52.37M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $23.24M derived: sum of 2 quarters · filed 2022-03-03 | $23.90M derived: sum of 3 quarters · filed 2022-03-03 | $23.89M 10-K · filed 2022-03-03 | $23.90M 10-K · filed 2021-03-04 | |||
| 2020-09-30 | $23.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $23.90M derived: sum of 2 quarters · filed 2021-11-03 | $23.89M 10-Q · filed 2021-11-03 | $23.90M 10-Q · filed 2020-11-05 | $23.89M derived: sum of 4 quarters · filed 2021-11-03 | |||
| 2020-06-30 | $664.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $655.00K 10-Q · filed 2021-08-04 | $655.49K 10-Q · filed 2020-08-05 | $655.00K derived: sum of 3 quarters · filed 2021-08-04 | $655.00K derived: sum of 4 quarters · filed 2021-08-04 | |||
| 2020-03-31 | -$9.00K 10-Q · filed 2021-05-05 | -$9.36K 10-Q · filed 2020-05-14 | -$9.00K derived: sum of 2 quarters · filed 2021-05-05 | -$9.00K derived: sum of 3 quarters · filed 2021-05-05 | $4.95M derived: sum of 4 quarters · filed 2021-05-05 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $0.00 derived: sum of 2 quarters · filed 2021-03-04 | $4.96M derived: sum of 3 quarters · filed 2021-03-04 | $12.21M 10-K · filed 2021-03-04 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.96M derived: sum of 2 quarters · filed 2020-11-05 | $12.21M 10-Q · filed 2020-11-05 | $12.21M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $4.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $12.21M 10-Q · filed 2020-08-05 | $12.21M derived: sum of 3 quarters · filed 2020-08-05 | $12.21M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | $7.25M 10-Q · filed 2020-05-14 | $7.25M derived: sum of 2 quarters · filed 2020-05-14 | $7.25M derived: sum of 3 quarters · filed 2020-05-14 | $7.25M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $0.00 derived: sum of 2 quarters · filed 2020-03-11 | $0.00 derived: sum of 3 quarters · filed 2020-03-11 | $900.00K 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | $900.00K 10-Q · filed 2019-11-08 | |||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $900.00K 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | $900.00K 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | $2.06M 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |